Korro Bio (KRRO) Research & Development (2018 - 2026)

Korro Bio's Research & Development history runs 9 years deep, the most recent figure standing at $13.0 million for Q1 2026.

• Quarterly Research & Development fell 34.39% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.8 million (down 15.78% YoY) and the FY2025 annual result came in at $65.6 million, up 3.05% from the prior year.
• Research & Development was $13.0 million for Q1 2026 at Korro Bio, up from $11.0 million in the prior quarter.
• Across five years, Research & Development topped out at $21.0 million in Q2 2025 and bottomed at -$39.3 million in Q4 2023.
• A 5-year average of $11.0 million and a median of $13.8 million in 2022 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2023 — Research & Development sank 1245.92% — and 2024, when it surged 143.13%.
• Korro Bio's Research & Development stood at $3.4 million in 2022, then sank by 1245.92% to -$39.3 million in 2023, then jumped by 143.13% to $17.0 million in 2024, then plunged by 35.24% to $11.0 million in 2025, then grew by 17.9% to $13.0 million in 2026.
• Business Quant data shows KRRO's Research & Development at $13.0 million in Q1 2026, $11.0 million in Q4 2025, and $13.8 million in Q3 2025.